Spectrum

Vital Intelligence for Pharmaceutical and Biotechnology Decision Makers

Spectrum is a comprehensive executive advisory service that identifies and analyzes key business and technology drivers of the pharmaceutical and biotechnology markets. A mix of publications and telephone inquiry access provide an “over the horizon” perspective for decision makers wrestling with complex issues and opportunities in the following areas:

• Pharmaceutical Industry Dynamics
• Therapy Markets and Emerging Technologies
• Biomarkers and Diagnostics
• Pharmacoeconomics, Pricing, and Reimbursement
• Drug Discovery and Design

Spectrum publishes over 70 executive reports each year. Important advisers in the business community, thought leaders in the healthcare industry, and analysts from Decision Resources make up the pool of authors who give their expert opinions in the Spectrum service.

A full subscription to the entire Spectrum series allows you to:

• Track industry trends and events in order to facilitate planning decisions.
• Increase awareness of competitors, areas of opportunity, and potential hurdles to success.
• Make informed choices regarding the license or acquisition of new technologies, platforms, and chemical entities.
• Formulate effective product-life-cycle-management strategies.
• Improve global pricing and reimbursement strategies.

Our most recent Spectrum reports:

Lessons Learned from the Current Crop of Biotech Startups

R&D Update: What's on the Horizon for the Panic Disorder Market?

Pharmaceutical Pricing and Reimbursement News in the Second Quarter of 2008

SPECIAL REPORT: Key Pricing and Reimbursement Trends for CNS Drugs

Dealmaking and Financing: Mergers and Acquisitions in Key Markets

Download our Spectrum brochure

View 2008 Spectrum report titles